Amplitude Surgical (AMPLI) Q1 24/25 earnings summary

Executive summary

• Q1 2024-25 consolidated sales reached €21.8m, up 7.5% at constant exchange rates compared to Q1 2023-24.

• Growth driven by strong international subsidiary performance and continued momentum in France.

Financial highlights

• Sales increased 6.1% at current exchange rates and 7.5% at constant exchange rates year-over-year.

• Direct sales (France and international subsidiaries) represented nearly 93% of total sales, rising 8.5% at constant exchange rates.

• France contributed about 67% of total Q1 sales.

Segment performance

• French sales grew 4.5% year-over-year.

• International subsidiaries' sales rose 14.1% at current and 20.1% at constant exchange rates.

• International distributor sales declined by 4.1%.

• Strong growth in Belgium, Australia, and Brazil; declines in Switzerland and Germany.